Cargando…

Semi Mature Blood Dendritic Cells Exist in Patients with Ductal Pancreatic Adenocarcinoma Owing to Inflammatory Factors Released from the Tumor

BACKGROUND: Much evidence exists regarding the fact that blood DCs, both myeloid DCs (MDCs) and plasmacytoid DCs (PDCs), are negatively affected in different types of cancer, with both reduced numbers and impaired functionality. Functional impairment of DCs in patients with pancreatic ductal adenoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Tjomsland, Vegard, Spångeus, Anna, Sandström, Per, Borch, Kurt, Messmer, Davorka, Larsson, Marie
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955544/
https://www.ncbi.nlm.nih.gov/pubmed/20976171
http://dx.doi.org/10.1371/journal.pone.0013441
_version_ 1782188035934257152
author Tjomsland, Vegard
Spångeus, Anna
Sandström, Per
Borch, Kurt
Messmer, Davorka
Larsson, Marie
author_facet Tjomsland, Vegard
Spångeus, Anna
Sandström, Per
Borch, Kurt
Messmer, Davorka
Larsson, Marie
author_sort Tjomsland, Vegard
collection PubMed
description BACKGROUND: Much evidence exists regarding the fact that blood DCs, both myeloid DCs (MDCs) and plasmacytoid DCs (PDCs), are negatively affected in different types of cancer, with both reduced numbers and impaired functionality. Functional impairment of DCs in patients with pancreatic ductal adenocarcinoma (PDAC), may contribute to the poor clinical outcome. The aim of this study was to examine the effects PDAC had on blood DCs and elucidate the underlying mechanism responsible for the DC impairment. METHODOLOGY/PRINCIPAL FINDINGS: We examined the systemic influence PDAC exerted on blood DCs by ex vivo measuring numerous activation and maturation markers expressed on these cells. Furthermore, the effect patient plasma and the inflammatory factors CXCL8 and PGE(2) had on purified MDCs and PDCs from healthy donors was assessed and compared to the DCs existing in PDAC patients. We found a partial maturation of the blood MDCs and PDCs in PDAC patients with significantly enhanced expression of CD83, CD40, B7H3, PDL-1, CCR6, and CCR7 and decreased expression of ICOSL, and DCIR. These changes lead to impairment in their immunostimulatory function. Furthermore, chronic pancreatitis gave rise to DCs with similar semi-mature phenotype as seen in PDAC. Low expression of ICOSL was associated with poor prognosis. We found that the mechanism underlying this semi-maturation of DCs was inflammatory factors existing in the PDAC patients' plasma. Of note, PGE(2), which is elevated PDAC patient plasma, was one contributing factor to the changes seen in MDCs and PDCs phenotype. CONCLUSION/SIGNIFICANCE: Our findings point to a role for the systemic inflammation in transforming blood MDCs and PDCs into semi-mature cells in PDAC patients and we show a correlation between maturation status and clinical outcome. Thus, means to preserve a functional blood DC compartment in PDAC patients by diminishing the inflammation could facilitate their ability to control the disease and improve survival.
format Text
id pubmed-2955544
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29555442010-10-25 Semi Mature Blood Dendritic Cells Exist in Patients with Ductal Pancreatic Adenocarcinoma Owing to Inflammatory Factors Released from the Tumor Tjomsland, Vegard Spångeus, Anna Sandström, Per Borch, Kurt Messmer, Davorka Larsson, Marie PLoS One Research Article BACKGROUND: Much evidence exists regarding the fact that blood DCs, both myeloid DCs (MDCs) and plasmacytoid DCs (PDCs), are negatively affected in different types of cancer, with both reduced numbers and impaired functionality. Functional impairment of DCs in patients with pancreatic ductal adenocarcinoma (PDAC), may contribute to the poor clinical outcome. The aim of this study was to examine the effects PDAC had on blood DCs and elucidate the underlying mechanism responsible for the DC impairment. METHODOLOGY/PRINCIPAL FINDINGS: We examined the systemic influence PDAC exerted on blood DCs by ex vivo measuring numerous activation and maturation markers expressed on these cells. Furthermore, the effect patient plasma and the inflammatory factors CXCL8 and PGE(2) had on purified MDCs and PDCs from healthy donors was assessed and compared to the DCs existing in PDAC patients. We found a partial maturation of the blood MDCs and PDCs in PDAC patients with significantly enhanced expression of CD83, CD40, B7H3, PDL-1, CCR6, and CCR7 and decreased expression of ICOSL, and DCIR. These changes lead to impairment in their immunostimulatory function. Furthermore, chronic pancreatitis gave rise to DCs with similar semi-mature phenotype as seen in PDAC. Low expression of ICOSL was associated with poor prognosis. We found that the mechanism underlying this semi-maturation of DCs was inflammatory factors existing in the PDAC patients' plasma. Of note, PGE(2), which is elevated PDAC patient plasma, was one contributing factor to the changes seen in MDCs and PDCs phenotype. CONCLUSION/SIGNIFICANCE: Our findings point to a role for the systemic inflammation in transforming blood MDCs and PDCs into semi-mature cells in PDAC patients and we show a correlation between maturation status and clinical outcome. Thus, means to preserve a functional blood DC compartment in PDAC patients by diminishing the inflammation could facilitate their ability to control the disease and improve survival. Public Library of Science 2010-10-15 /pmc/articles/PMC2955544/ /pubmed/20976171 http://dx.doi.org/10.1371/journal.pone.0013441 Text en Tjomsland et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Tjomsland, Vegard
Spångeus, Anna
Sandström, Per
Borch, Kurt
Messmer, Davorka
Larsson, Marie
Semi Mature Blood Dendritic Cells Exist in Patients with Ductal Pancreatic Adenocarcinoma Owing to Inflammatory Factors Released from the Tumor
title Semi Mature Blood Dendritic Cells Exist in Patients with Ductal Pancreatic Adenocarcinoma Owing to Inflammatory Factors Released from the Tumor
title_full Semi Mature Blood Dendritic Cells Exist in Patients with Ductal Pancreatic Adenocarcinoma Owing to Inflammatory Factors Released from the Tumor
title_fullStr Semi Mature Blood Dendritic Cells Exist in Patients with Ductal Pancreatic Adenocarcinoma Owing to Inflammatory Factors Released from the Tumor
title_full_unstemmed Semi Mature Blood Dendritic Cells Exist in Patients with Ductal Pancreatic Adenocarcinoma Owing to Inflammatory Factors Released from the Tumor
title_short Semi Mature Blood Dendritic Cells Exist in Patients with Ductal Pancreatic Adenocarcinoma Owing to Inflammatory Factors Released from the Tumor
title_sort semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955544/
https://www.ncbi.nlm.nih.gov/pubmed/20976171
http://dx.doi.org/10.1371/journal.pone.0013441
work_keys_str_mv AT tjomslandvegard semimatureblooddendriticcellsexistinpatientswithductalpancreaticadenocarcinomaowingtoinflammatoryfactorsreleasedfromthetumor
AT spangeusanna semimatureblooddendriticcellsexistinpatientswithductalpancreaticadenocarcinomaowingtoinflammatoryfactorsreleasedfromthetumor
AT sandstromper semimatureblooddendriticcellsexistinpatientswithductalpancreaticadenocarcinomaowingtoinflammatoryfactorsreleasedfromthetumor
AT borchkurt semimatureblooddendriticcellsexistinpatientswithductalpancreaticadenocarcinomaowingtoinflammatoryfactorsreleasedfromthetumor
AT messmerdavorka semimatureblooddendriticcellsexistinpatientswithductalpancreaticadenocarcinomaowingtoinflammatoryfactorsreleasedfromthetumor
AT larssonmarie semimatureblooddendriticcellsexistinpatientswithductalpancreaticadenocarcinomaowingtoinflammatoryfactorsreleasedfromthetumor